. the study used data of 1,082 ct scans of stroke patients across 70 hospitals in britain..: "arise: a phase 3 randomized trial of erenumab for episodic migraine."..
.
�we have waited a long time and we cannot possibly wait any longer.�..
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..